Cardiovasc Drugs Ther
From Bioblast
Revision as of 18:12, 28 May 2020 by Plangger Mario (talk | contribs) (Created page with "{{Journal |Title=[https://www.springer.com/journal/10557 Cardiovascular Drugs and Therapy] }}")
| Journal title and website | Cardiovascular Drugs and Therapy |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Alexander 2022 Cardiovasc Drugs Ther | Alexander ED, Aldridge JL, Burleson TS, Frasier CR (2022) Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts. https://doi.org/10.1007/s10557-022-07341-z | 2022 | Cardiovasc Drugs Ther 37:1021-26. PMID: 35488973 Open Access |
| Larsen 2020 Cardiovasc Drugs Ther | Larsen AH, Wiggers H, Dollerup OL, Jespersen NR, Hansson NH, Frøkiær J, Brøsen K, Nørrelund H, Bøtker HE, Møller N, Jessen N (2020) Metformin lowers body weight but fails to increase insulin sensitivity in chronic heart failure patients without diabetes: a randomized, double-blind, placebo-controlled study. Cardiovasc Drugs Ther 35:491-503. | 2020 | PMID: 32770520 |
| Makrecka-Kuka 2020 Cardiovasc Drugs Ther | Makrecka-Kuka Marina, Korzh Stanislava, Videja Melita, Vilks Karlis, Cirule Helena, Kuka Janis, Dambrova Maija, Liepinsh Edgars (2020) Empagliflozin protects cardiac mitochondrial fatty acid metabolism in a mouse model of diet-induced lipid overload. Cardiovasc Drugs Ther 34:791-97. | 2020 | PMID: 32424653 |
